Tag

larynx

NanOx incompletely predicted laryngeal cancer cell survival across a helium Bragg peak

NanOx predictions differed from measured laryngeal cancer cell survival by 20–37% and overestimated the distal biological gradient.

Escalating metabolically active disease to 73.5 Gy did not improve locoregional control, disease-free survival, or overall survival versus 66 Gy.